Does $760m a year of industry funding affect the FDA's drug approval process?

Sidney M. Wolfe

Research output: Contribution to journalArticle

Original languageEnglish (US)
Article numberg5012
JournalBMJ (Online)
Volume349
DOIs
StatePublished - Aug 5 2014
Externally publishedYes

Fingerprint

Safety-Based Drug Withdrawals
Postmarketing Product Surveillance
Drug Approval
Drug Industry
United States Food and Drug Administration
Industry

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Does $760m a year of industry funding affect the FDA's drug approval process? / Wolfe, Sidney M.

In: BMJ (Online), Vol. 349, g5012, 05.08.2014.

Research output: Contribution to journalArticle

@article{abab54ec44bc48d28a86229c2142a336,
title = "Does $760m a year of industry funding affect the FDA's drug approval process?",
author = "Wolfe, {Sidney M.}",
year = "2014",
month = "8",
day = "5",
doi = "10.1136/bmj.g5012",
language = "English (US)",
volume = "349",
journal = "British Medical Journal",
issn = "0959-8146",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Does $760m a year of industry funding affect the FDA's drug approval process?

AU - Wolfe, Sidney M.

PY - 2014/8/5

Y1 - 2014/8/5

UR - http://www.scopus.com/inward/record.url?scp=84905455150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905455150&partnerID=8YFLogxK

U2 - 10.1136/bmj.g5012

DO - 10.1136/bmj.g5012

M3 - Article

C2 - 25096994

AN - SCOPUS:84905455150

VL - 349

JO - British Medical Journal

JF - British Medical Journal

SN - 0959-8146

M1 - g5012

ER -